Sign in
HELX Stock Price, Chart, Stats & News
Franklin Genomic Advancements ETF
Save
Franklin Genomic Advancements ETF (HELX) is a dividend-paying ETF with a current dividend yield of 0.34% as of Nov 13, 2026. It pays $0.1433 per share over the trailing twelve months and distributes annually. Its dividend has grown at a 22.48% 5-year compound annual rate.
Healthcare Equity
Category
0.34%
Dividend yield
$0.1433
0.50%
Expense ratio
35.23M
Assets
22.81%
1Y return
HELX chart
HELX returns
| YTD | 15.51% |
| 1Y | 22.81% |
| 3Y | 17.02% |
| 5Y | -3.57% |
| 10Y | 0.00% |
| 1Y volatility | 19.48% |
| 3Y volatility | 19.83% |
| Sharpe ratio | 0.84 |
About
This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements.
Top 10 HELX holdings
| Holding | Ownership |
|---|---|
Health care 8.71% | |
Health care 7.97% | |
Health care 5.10% | |
Health care 4.67% | |
Health care 4.53% | |
Health care 3.71% | |
Health care 3.32% | |
Health care 2.88% | |
Health care 2.76% | |
Health care 2.74% |
Related lists
Similar securities
Based on sector and market capitalization
Report issue